ATE332372T1 - Rezeptor von dendritischen zellen. - Google Patents

Rezeptor von dendritischen zellen.

Info

Publication number
ATE332372T1
ATE332372T1 AT97923357T AT97923357T ATE332372T1 AT E332372 T1 ATE332372 T1 AT E332372T1 AT 97923357 T AT97923357 T AT 97923357T AT 97923357 T AT97923357 T AT 97923357T AT E332372 T1 ATE332372 T1 AT E332372T1
Authority
AT
Austria
Prior art keywords
human dec
extracellular domain
receptor
functionally equivalent
dendritic cells
Prior art date
Application number
AT97923357T
Other languages
English (en)
Inventor
Derek Nigel John Hart
Original Assignee
Derek Nigel John Hart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Derek Nigel John Hart filed Critical Derek Nigel John Hart
Application granted granted Critical
Publication of ATE332372T1 publication Critical patent/ATE332372T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97923357T 1996-05-29 1997-05-29 Rezeptor von dendritischen zellen. ATE332372T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ28669296 1996-05-29

Publications (1)

Publication Number Publication Date
ATE332372T1 true ATE332372T1 (de) 2006-07-15

Family

ID=19925770

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923357T ATE332372T1 (de) 1996-05-29 1997-05-29 Rezeptor von dendritischen zellen.

Country Status (7)

Country Link
US (4) US6432666B1 (de)
EP (1) EP1015489B1 (de)
JP (2) JP2000512490A (de)
AT (1) ATE332372T1 (de)
AU (1) AU738557C (de)
DE (1) DE69736306T2 (de)
WO (1) WO1997045449A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040258688A1 (en) * 1995-01-31 2004-12-23 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
US20020187131A1 (en) * 1995-01-31 2002-12-12 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom
GB9808327D0 (en) * 1998-04-20 1998-06-17 Chiron Spa Antidiotypic compounds
AU6130299A (en) * 1998-08-19 2000-03-14 Immtech International, Inc. Use of mcrp for delivery of materials into cells
US7263073B2 (en) * 1999-03-18 2007-08-28 Statsignal Ipc, Llc Systems and methods for enabling a mobile user to notify an automated monitoring system of an emergency situation
KR100881471B1 (ko) 2000-05-08 2009-02-05 셀덱스 쎄라퓨틱스, 인크. 수상세포에 대한 인간 모노클로날 항체
US7560534B2 (en) 2000-05-08 2009-07-14 Celldex Research Corporation Molecular conjugates comprising human monoclonal antibodies to dendritic cells
WO2002022683A1 (fr) * 2000-09-12 2002-03-21 Kirin Beer Kabushiki Kaisha Nouvelle membrane a paroi cellulaire dendritique et son utilisation
AUPR298901A0 (en) * 2001-02-07 2001-03-08 McComb Foundation, Inc., The Cell suspension preparation technique and device
US20040146948A1 (en) * 2002-10-18 2004-07-29 Centenary Institute Of Cancer Medicine And Cell Biology Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
US20060281672A1 (en) * 2002-12-06 2006-12-14 Hart Derek N J Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
ATE552860T1 (de) 2003-01-31 2012-04-15 Celldex Res Corp Antikörper-vakzine-konjugate und ihre verwendungen
US9259459B2 (en) * 2003-01-31 2016-02-16 Celldex Therapeutics Inc. Antibody vaccine conjugates and uses therefor
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
AU2013201417B2 (en) * 2007-11-07 2015-05-21 Celldex Therapeutics Inc. Antibodies that bind human dendritic and epithelial cell 205 (DEC-205)
CN101888856B (zh) * 2007-11-07 2014-08-27 塞尔德克斯医疗公司 结合人树突和上皮细胞205(dec-205)的抗体
AU2010303304A1 (en) * 2009-10-08 2012-05-17 President And Fellows Of Harvard College Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
GB201220010D0 (en) * 2012-11-07 2012-12-19 Oxford Biotherapeutics Ltd Therapeutic amd diagnostic target
AU2013205148B2 (en) 2013-03-14 2014-10-30 AVITA Medical Americas, LLC Systems and methods for tissue processing and preparation of cell suspension therefrom
CN105745224B (zh) * 2013-10-11 2019-11-05 牛津生物疗法有限公司 用于治疗癌症的针对ly75的偶联抗体
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10513350A (ja) * 1995-01-31 1998-12-22 ザ ロックフェラー ユニヴァーシティ ＤＥＣ（樹状細胞及び上皮細胞、２０５ ｋＤａ）の同定、Ｃ型レクチンドメインを有するレセプター、ＤＥＣをコードする核酸、及びこれらの使用
US20040258688A1 (en) * 1995-01-31 2004-12-23 Daniel Hawiger Enhanced antigen delivery and modulation of the immune response therefrom

Also Published As

Publication number Publication date
AU2917697A (en) 1998-01-05
US20030082707A1 (en) 2003-05-01
US20050186612A1 (en) 2005-08-25
DE69736306T2 (de) 2007-06-14
AU738557B2 (en) 2001-09-20
EP1015489A1 (de) 2000-07-05
US6432666B1 (en) 2002-08-13
EP1015489A4 (de) 2001-02-14
US8618262B2 (en) 2013-12-31
JP2000512490A (ja) 2000-09-26
WO1997045449A1 (en) 1997-12-04
EP1015489B1 (de) 2006-07-05
JP2009148287A (ja) 2009-07-09
AU738557C (en) 2003-08-21
US20100303818A1 (en) 2010-12-02
DE69736306D1 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
DE69736306D1 (de) Rezeptor von dendritischen zellen.
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
AU7697301A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
WO1999041383A8 (en) Antigen library immunization
NO20013906D0 (no) Fremgangsmater for behandling av tumorer og metastaser ved a bruke en kombinasjon av antiangiogeniske- og immunoterapier
NO923953D0 (no) Peptider
DE69703121D1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
EA200501560A1 (ru) Предотвращение и терапия амилоидогенной болезни
TR199801722T2 (xx) Peptit imm�nojenler.
ATE483806T1 (de) Polynukleotide, welche für mitglieder der humanen b lymphozyten-aktivierendes antigen familie kodieren, und von diesen kodierte polypeptide
ATE356206T1 (de) Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen
NL300830I2 (nl) Protein Q, een recombinant chimeer eiwit, bestaande uit vijf antigenefragmenten van vier verschillende Leishmania infantum (zymodeme Mon-1) eiwitten
IL150115A (en) Isolated antibody that binds to rg1 polypeptides, immunosuppressant containing this antibody, antibody uses, and methods utilizing it
EP2193804A3 (de) Rekombinantes Adenylat-Cyclase-Toxin von Bordetella induziert T-Zell-Antworten gegen tumorale Antigene
ATE417112T1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
NO950526D0 (no) T-celleepitoper av raigresspollen-allergen
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
DK0938329T3 (da) Immunogen TLP sammensætning
NZ333191A (en) Human dendritic cell receptor DEC-205
ATE480250T1 (de) Neue trp2-isoform mit cytotoxischen t-lymphozyten-epitopen mit hla-a2-restriktion
CY1108790T1 (el) Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου
WO2001083684A3 (fr) Nouveau polypeptide, proteine humaine krab kraz2-12 a doigt de zinc, et polynucleotide codant pour ce polypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties